Ukwelashwa okungahlaseli kwe-sarcoma

Yabelana ngalokhu okuthunyelwe

I-radiotherapy enembile iyindlela ebaluleke kakhulu yokwelapha umdlavuza. Amasu anembile we-radiotherapy amelwe ummese wangaphambili osheshayo, ummese we-proton, i-ion esindayo, njll., angenza ukuhlinzwa okukhulu kanye nokwelashwa okuwusizo kweziguli ezinomdlavuza. To understand the progress of radiotherapy, sarcoma is more common in young people, is a malignant tumor derived from mesenchymal tissue (including connective tissue and muscle). Sarcomas are highly malignant and develop rapidly! Common scomcom include osteosarcoma, leiomyoma, lymphosarcoma, synovial sarcoma, etc.   
Indlela ekhethwayo ye-sarcoma ukuhlinzwa. Ukuze bathole ukwelashwa okuqinile, odokotela basekhaya ngokuvamile bafuna ukuba iziguli zinqunywe izitho zomzimba. , Iziguli eziningi kunzima ukuzelapha. I-Sarcoma ayizweli ku-chemotherapy. I-radiotherapy ejwayelekile nayo kunzima ukubulala izicubu, kanti i-leiomyoma, i-lymphosarcoma, ne-synovial sarcoma zijwayele isifo se-metastasis ngegazi. Ngakho-ke, ukwelashwa kwe-sarcoma kufanele kube ngokushesha okukhulu futhi ngokushesha okukhulu.

The EDGE Radiosurgery system (EDGE radiosurgery isisu treatment system) was developed by the American Varian company and was approved by the US FDA on January 23, 2013. The EDGE blade is by far the most effective non-invasive tumor removal technology, using the unique FDA’s Calypso® GPS for the Body® system and surface beam monitoring system approved on July 21, 2014 with high-frequency real-time dynamics of up to 10 ms Monitor and lock the tumor “escape” during the treatment process, combined with the new generation IGRT and other image guidance technology, using the unique high-intensity HD-MLC collimator up to 2400MU / min to remove tumor tissue with sub-millimeter accuracy with almost no residue . 

Izici eziyingqayizivele zommese wesivinini se-EDGE, imisebe enamandla kakhulu efinyelela ku-2400MU / min, ingaphula ngokushesha i-DNA yamangqamuzana e-tumor, futhi ekugcineni ibangele ukufa kwamaseli, futhi isimila simuncwe noma sibe nezibazi. Ukunemba kommese we-EDGE kuphakeme njengo-0.1mm. 

Bhalisa ku-Newsletter yethu

Thola izibuyekezo futhi ungalokothi uphuthelwe ibhulogi evela kuCancerfax

Okuningi Okuzohlolwa

I-CAR T Cell Therapy Esekelwe Kubantu: Ukuphumelela Nezinselele
Ukwelashwa kwe-CAR T-Cell

I-CAR T Cell Therapy Esekelwe Kubantu: Ukuphumelela kanye Nezinselele

Ukwelashwa kwe-CAR T-cell okusekelwe kumuntu kuguqula ukwelashwa komdlavuza ngokushintsha izakhi zofuzo amaseli omzimba esiguli ukuze aqondise futhi abhubhise amaseli omdlavuza. Ngokusebenzisa amandla esimiso somzimba sokuzivikela ezifweni, lezi zindlela zokwelapha zinikeza ukwelashwa okunamandla futhi okuqondene nomuntu okungahle kube nokuxolelwa okuhlala isikhathi eside ezinhlotsheni ezihlukahlukene zomdlavuza.

Ukuqonda I-Cytokine Release Syndrome: Izimbangela, Izimpawu, Nokwelashwa
Ukwelashwa kwe-CAR T-Cell

Ukuqonda I-Cytokine Release Syndrome: Izimbangela, Izimpawu, Nokwelashwa

I-Cytokine Release Syndrome (CRS) iwukusabela kwamasosha omzimba okuvame ukubangelwa izindlela zokwelapha ezithile ezifana ne-immunotherapy noma i-CAR-T cell therapy. Kuhilela ukukhululwa ngokweqile kwama-cytokines, okubangela izimpawu ezisukela kumkhuhlane nokukhathala kuya ezinkingeni ezingase zibeke ukuphila engozini njengokulimala kwesitho. Ukuphatha kudinga ukuqapha ngokucophelela kanye namasu okungenelela.

Dinga usizo? Ithimba lethu likulungele ukukusiza.

Sifisela ukululama okusheshayo kothandekayo wakho futhi oseduze.

Qala ingxoxo
Siku-inthanethi! Xoxa Nathi!
Skena ikhodi
Sawubona,

Siyakwamukela kuCancerFax!

ICancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza oseqophelweni eliphezulu ngemithi yokwelapha yamangqamuzana efana ne-CAR T-Cell therapy, ukwelashwa kwe-TIL, nezivivinyo zomtholampilo emhlabeni wonke.

Sazise ukuthi yini esingakwenzela yona.

1) Ukwelashwa komdlavuza phesheya?
2) Ukwelashwa kwe-CAR T-Cell
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton